CPBTD
WST icon

Central Pacific Bank - Trust Division’s West Pharmaceutical WST Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,320
Closed -$435K – 959
2024
Q2 		$435K Buy
1,320
+100
+8% +$35.3K 0.05% 345
2024
Q1 		$483K Buy
+1,220
New +$451K 0.06% 337

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Central Pacific Bank - Trust Division's WST Position: Q3 2024 in Review

Central Pacific Bank - Trust Division sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 1,320 shares — an estimated $435K sold.

Central Pacific Bank - Trust Division first reported a position in WST in Q1 2024 and held it in 2 quarters. The position peaked at $483K in Q1 2024. 729 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Central Pacific Bank - Trust Division reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Central Pacific Bank - Trust Division sold 1,320 West Pharmaceutical shares in Q3 2024, an estimated $435K.
  • Central Pacific Bank - Trust Division first reported a position in West Pharmaceutical in Q1 2024 and held it in 2 quarters.
  • Central Pacific Bank - Trust Division's West Pharmaceutical position peaked at $483K in Q1 2024.
  • 729 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2024, filed 2 Oct 2024.